Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
Q3 LONG ANSWER 10M ★ High-yield

Define pulmonary hypertension and cor pulmonale. Classify pulmonary hypertension and describe its pathogenesis and morphology.

Pathology · 2nd Professional — Para-Clinical

Definition

Pulmonary hypertension is a sustained elevation of the mean pulmonary artery pressure above 20 mmHg at rest. cor pulmonale is right ventricular hypertrophy and eventual failure caused by disease of the lungs or pulmonary vasculature, and not by left heart or congenital heart disease.

  • Normal pulmonary artery pressure is about 25/10 mmHg, mean 14 — roughly a sixth of systemic pressure
  • The pulmonary circulation is a low-pressure, low-resistance, high-compliance system, which is why the right ventricle is thin-walled and copes badly with a sudden pressure load
  • The exclusion of left heart disease is what defines cor pulmonale — right ventricular failure secondary to left ventricular failure is not cor pulmonale, and is in fact its commonest mimic

Clinical Classification

GroupCategoryExamples
1Pulmonary arterial hypertensionIdiopathic (BMPR2 mutation), heritable, drug-induced (appetite suppressants), connective tissue disease (systemic sclerosis), HIV, portal hypertension, congenital left-to-right shunts, schistosomiasis (an important cause worldwide)
2Due to left heart disease — the commonest group overallLeft ventricular systolic or diastolic failure; mitral stenosis and other valve disease
3Due to lung disease and/or hypoxiaCOPD (the commonest cause of cor pulmonale), interstitial lung disease, obstructive sleep apnoea, high altitude, kyphoscoliosis, obesity hypoventilation
4Chronic thromboembolic pulmonary hypertensionRecurrent pulmonary emboli — potentially curable by endarterectomy
5Multifactorial or unclearSarcoidosis, haematological disorders, metabolic disease

Pathogenesis

The initiating stimulus — hypoxia, loss of vascular bed, high flow, or raised left atrial pressure → hypoxic pulmonary vasoconstriction — unique to the lung, and normally useful because it diverts blood from poorly ventilated areas → When hypoxia is global and sustained, the whole pulmonary bed constricts → Endothelial dysfunction — reduced nitric oxide and prostacyclin, increased endothelin-1 and thromboxane → Smooth muscle proliferation and intimal thickening → vascular remodelling → In situ thrombosis in the small vessels → Fixed rise in pulmonary vascular resistance — no longer reversible with oxygen → Right ventricular pressure overload → hypertrophy → dilatation → failure

  • Hypoxic pulmonary vasoconstriction is the opposite of the systemic response, where hypoxia causes vasodilatation. In the lung it improves ventilation–perfusion matching — but applied to the whole lung it becomes the mechanism of disease
  • Early pulmonary hypertension is reversible with oxygen; once remodelling is established it is not, which is the argument for treating hypoxaemia early

Morphology

SiteChanges
Large elastic pulmonary arteriesAtheroma — which does not occur in a normal low-pressure pulmonary circulation, so its presence is itself evidence of hypertension
Medium muscular arteriesMedial hypertrophy and intimal fibrosis
Small arteries and arteriolesMedial hypertrophy, muscularisation of normally non-muscular arterioles, intimal proliferation, luminal narrowing and obliteration
Severe (grade VI) diseasePlexiform lesions — tufts of capillary-like channels within a dilated, thin-walled segment; characteristic of severe pulmonary arterial hypertension and of eisenmenger syndrome; irreversible
Right ventricleHypertrophy — wall over 5 mm (normally 3–5 mm); trabeculae coarse; later dilatation with functional tricuspid regurgitation
LiverNutmeg appearance from chronic venous congestion; "cardiac cirrhosis" in long-standing disease

CLINICAL PEARL

Plexiform lesions mark the point of no return. They represent disordered angiogenesis within an already obliterated arteriole, and their presence means the pulmonary vasculature can no longer remodel back. This is precisely why a left-to-right shunt must be closed before Eisenmenger physiology is established — after that, closing it leaves the right ventricle facing a fixed and insurmountable resistance.

Clinical Features and Investigation

  • Symptoms are non-specific and the diagnosis is often late — exertional dyspnoea and fatigue, then exertional chest pain, syncope on effort, and finally features of right heart failure
  • Signs of pulmonary hypertension — a loud pulmonary component of the second heart sound, a right ventricular heave, a right-sided fourth heart sound, and the early diastolic murmur of pulmonary regurgitation (Graham Steell)
  • Signs of right heart failure — raised jugular venous pressure with a prominent v wave, pansystolic murmur of tricuspid regurgitation, tender pulsatile hepatomegaly, ascites and dependent oedema
  • ECG — right axis deviation, P pulmonale (tall peaked P waves), right ventricular hypertrophy with dominant R in V1, right bundle branch block
  • Chest radiograph — enlarged central pulmonary arteries with peripheral "pruning", and right ventricular enlargement
  • Echocardiography is the screening test of choice, estimating pulmonary artery pressure from the tricuspid regurgitant jet and assessing the right ventricle and the left heart
  • Right heart catheterisation is the gold standard, and is the only way to measure pressure directly and to distinguish pre-capillary from post-capillary disease by the wedge pressure

Cor Pulmonale — Acute and Chronic

FeatureAcute cor pulmonaleChronic cor pulmonale
Usual causeMassive pulmonary embolismCOPD (much the commonest); interstitial lung disease; recurrent small emboli; kyphoscoliosis; sleep apnoea
OnsetMinutes to hoursMonths to years
Right ventricleDilatation only — there is no time to hypertrophyHypertrophy first, then dilatation
Wall thicknessNormalIncreased, over 5 mm
OutcomeSudden death or rapid recoveryProgressive right heart failure
  • The right ventricle tolerates a volume load far better than a pressure load — it is a thin-walled, compliant chamber built to eject into a low-resistance circuit. A sudden rise in afterload dilates and fails it within minutes, which is why a massive embolism kills so quickly
  • Chronic hypoxaemia also causes secondary polycythaemia, which raises viscosity and adds further to pulmonary vascular resistance — a vicious cycle
  • Cor pulmonale accounts for a substantial share of all heart failure in India, chiefly through COPD from smoking and biomass smoke, and through post-tuberculous lung damage

Applied Aspects

  • Treat the cause — in group 3, that means oxygen, treatment of COPD or interstitial disease, and continuous positive airway pressure for sleep apnoea; in group 2 it means treating the left heart
  • Long-term oxygen therapy for chronic hypoxaemia reduces pulmonary pressure and prolongs life; it is one of very few treatments in respiratory medicine that improves survival
  • Targeted pulmonary vasodilators — endothelin receptor antagonists (bosentan), phosphodiesterase-5 inhibitors (sildenafil) and prostacyclin analogues — are for group 1, and may be harmful in group 2 and group 3, where they worsen ventilation–perfusion matching or precipitate pulmonary oedema
  • Chronic thromboembolic disease must be sought, since pulmonary endarterectomy can be curative — the one potentially reversible form
  • Obstructive sleep apnoea is common and under-diagnosed, and is a readily treatable cause of cor pulmonale
  • Prognosis depends on right ventricular function rather than on the pressure itself — a failing right ventricle may show a falling pressure as it decompensates, which is an ominous rather than a reassuring sign
  • Diuretics relieve congestion but must be used cautiously, since the failing right ventricle is preload-dependent and over-diuresis drops cardiac output
  • Digoxin and vasodilators are of limited value in cor pulmonale, and systemic vasodilators may cause hypotension without lowering pulmonary pressure
  • Venesection is occasionally used for severe secondary polycythaemia with a haematocrit above about 55%
  • Pregnancy carries a very high mortality in pulmonary arterial hypertension and is strongly advised against; effective contraception must be discussed
  • Screen patients with systemic sclerosis annually by echocardiography, since pulmonary hypertension is now their leading cause of death and early treatment helps
  • Distinguishing group 2 from group 3 changes treatment entirely, and the wedge pressure at catheterisation is what settles it — which is why the invasive study cannot always be avoided

All questions in Respiratory Pathology

  1. Q1Define chronic obstructive pulmonary disease. Describe chronic bronchitis and emphysema with their types, pathogenesis and morphology. ★
  2. Q2Classify pneumonia. Describe the stages of lobar pneumonia and differentiate it from bronchopneumonia. ★
  3. Q3Define pulmonary hypertension and cor pulmonale. Classify pulmonary hypertension and describe its pathogenesis and morphology. ★
  4. Q4Classify carcinoma of the lung. Describe the morphology, local effects and spread of the major types. ★
  5. Q5Classify interstitial lung disease. Describe the pneumoconioses and idiopathic pulmonary fibrosis. ★
  6. SN1Describe bronchial asthma with its types, pathogenesis and morphology. ★
  7. SN2Define bronchiectasis. Describe its causes, pathogenesis and complications. ★
  8. SN3Describe acute respiratory distress syndrome with its causes, pathogenesis and morphology. ★
  9. SN4Describe lung abscess with its causes, morphology and complications. ★
  10. SN5Classify pleural effusion. Describe malignant mesothelioma and add a note on pneumothorax. ★
  11. SN6Define atelectasis. Classify it and describe its causes and consequences. ★
  12. SN7Describe sarcoidosis with its morphology, clinical features and diagnosis.

Every Pathology chapter →

Scroll to Top